Lidamidine
- Level
- Commodity
- Parent
- 51171700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171716This classification denotes an antidiarrheal agent with the molecular formula C11H16N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q8X04W8418, chemically known as urea, n-(2,6-dimethylphenyl)-n-(imino(methylamino)methyl)- but generally known as lidamidine, which bears US NIH Compound Identifier 47510. European Medicines Agency schedules Lidamidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08504MIG. The term LIDAMIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). LIDAMIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lidamidine under HS 29252900 and SITC 51482. As of Q4 2014, LIDAMIDINE remains the US FDA Preferred Term for this commodity. Lidamidine bears US NLM identifiers UMLS ID C0064961 and NCI Concept Code C82240. SMILES: CC1=C(C(=CC=C1)C)NC(=O)NC(=NC)N.
Same parent
Under 51171700 · 24Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.